5.00k followers • 15 symbols Watchlist by Yahoo Finance
This basket consists of stocks that serve the 18+ crowd, such as casinos, alcohol, tobacco, and strip clubs.
Philip Morris International Inc.
Anheuser-Busch InBev SA/NV
Altria Group, Inc.
Constellation Brands, Inc.
Las Vegas Sands Corp.
MGM Resorts International
Wynn Resorts, Limited
Molson Coors Beverage Company
The Boston Beer Company, Inc.
Penn National Gaming, Inc.
Boyd Gaming Corporation
Red Rock Resorts, Inc.
RCI Hospitality Holdings, Inc.
The first pick is Walt Disney (NYSE: DIS), a diversified entertainment company trading at an attractive discount because of the coronavirus pandemic. The second pick is Altria (NYSE: MO), a tobacco giant that has raised its dividend for five decades in a row. Walt Disney rides a fine line between value and growth.
The current health scare drives market volatility and calls for investment in consumer staples, healthcare and IT sectors for stable returns.
Red Rock Resorts' (RRR) focus on Palace Station and Palms redevelopment projects bodes well. However, decline in traffic due to the coronavirus outbreak is concerning.
With reinvestment, only minimal to modest share price appreciation would be needed to double your money with these brand-name companies.
Altria Group, Inc. (Altria) (NYSE: MO) announces today that the U.S. Food and Drug Administration (FDA) authorized the marketing of the IQOS tobacco heating system as a modified risk tobacco product with a reduced exposure claim. IQOS is the first next-generation inhalable tobacco product to be authorized as a modified risk tobacco product. Unlike cigarettes, the IQOS system heats but does not burn tobacco. Philip Morris USA (PM USA), under an exclusive licensing agreement with Philip Morris International (PMI), commercializes IQOS in the United States.
FDA Authorizes Marketing of IQOS as a Modified Risk Tobacco Product
For many investors, the main point of stock picking is to generate higher returns than the overall market. But its...
In a potential win for international tobacco titan Philip Morris (NYSE: PM), the FDA approved its "heatsticks" and the associated electronic IQOS device for marketing as a "reduced exposure" tobacco product, offering reduced exposure to the substances found in ordinary cigarettes or cigars. The authorization lets Philip Morris advertise the items as safer "modified risk tobacco products," or MRTPs. Instead of involving actual combustion of tobacco leaves and preservative chemicals in a traditional smoking item such as a cigarette, the IQOS and heatstick system takes a different approach.
Penn National's (PENN) focus on strategic partnerships and margin-improvement initiatives bode well. However, a decline in traffic due to the coronavirus outbreak is concerning.
Shares of Diageo (NYSE: DEO) fell 16.2% over the first six months of 2020, according to data from S&P Global Market Intelligence, versus a 3% loss for the S&P 500 index. While the coronavirus pandemic ought to have benefited alcohol producers like distiller Diageo, which owns the best-selling Scotch whisky brand Johnnie Walker, the required closure of bars, restaurants, and nightclubs removed a large swath of its business. Analysts say spirits like Scotch whisky are more apt to be consumed in those kinds of premises than at home, where beer and other alcoholic beverages like hard seltzer have a better chance of success.
Shares of Anheuser-Busch InBev (NYSE: BUD) fell 39.7% over the first six months of 2020, according to data from S&P Global Market Intelligence, versus a 3% loss for the S&P 500 index. Part of Anheuser-Busch's problem is that beer consumption remains on the decline in the U.S. Consumer preferences overseas aren't shifting so dramatically, but the domestic market is the company's largest. While the brewer is participating in the hard seltzer trend — one of the fastest-growing segments in alcohol — it trails far behind the category's leaders, like Mark Anthony Brands' White Claw and Boston Beer's Truly.
What happened Boston Beer (NYSE: SAM) shareholders are trouncing the market this year. Their stock jumped 42% compared to a 4% decline in the S&P 500 through the end of June, according to data provided by S&P Global Market Intelligence.
Rather than developing its own vaccine in the global race to combat the pandemic, GSK has instead focused on contributing its adjuvant technology to at least seven other global companies, including Sanofi <SAY.PA> and China's Clover. The latest deal, with Canadian firm Medicago, uses plant-based technology that differs from GSK's other coronavirus-partnerships and boosts the London-listed company's chances of finding a successful candidate and scaling production relatively quickly. There are no approved vaccines for the respiratory illness caused by the new coronavirus, but 19 vaccines are being trialled in humans globally and some treatments, such as Gilead's <GILD.O> remdesivir, have been approved in certain regions.
First up is General Mills (NYSE: GIS). While some industries' revenues evaporated, General Mills accelerated its growth. For fiscal 2020, the General Mills pet food segment grew 18%, tripling the overall company's pace, and there is reason to believe that can continue.
The brewer has had a rough ride over the past year, but its huge portfolio of leading brands is a major competitive advantage Continue reading...
(MO) stock has had a tough 2020, and Barclays argues that there is little in the way of catalysts for the tobacco firm. Analyst Gaurav Jain cut his rating on the shares to Equal Weight from Overweight on Wednesday, and lowered his price target by $7 to $43. Jain writes that he previously thought that (MO) stock (ticker: MO) would get a boost from improving cigarette sales—and other analysts had argued the same, as stress and boredom during lockdowns led to more tobacco use.
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
ROAR Digital, LLC ("ROAR" or the "Company") – the US sports betting and online gaming company operating as BetMGM and owned jointly by MGM Resorts International (NYSE: MGM) ("MGM Resorts") and GVC Holdings (LSE: GVC) ("GVC") – announced today that its shareholders have committed to a second round of investment, bringing the total to $450 million. This increase follows MGM Resorts' and GVC's total initial commitment of $200 million and underpins their commitment to BetMGM becoming a leading player in the rapidly growing US sports betting and iGaming markets. These two rounds of investment provide the Company with over $370 million of investable capital at present.
Wynn Las Vegas (Nasdaq: WYNN) has been ranked the No. 1 hotel in Las Vegas on the Travel + Leisure 2020 World's Best Awards list honoring the top hotels, travel destinations, and companies worldwide, as rated by its readers. This year marks the first time that Las Vegas has received its own city-specific list in the Award's 25-year history.
The U.S. Food and Drug Administration has now authorized the marketing of Philip Morris International’s (PM) “IQOS Tobacco Heating System” as modified risk tobacco products (MRTPs). Shares in PM rose 3.3% in Tuesday’s trading.This marks the second set of products ever to be authorized as MRTPs and the first tobacco products to receive “exposure modification” orders- which permits the marketing of a product as containing a reduced level of or exposure to a substance or as being free of a substance when the issuance of the order is expected to benefit the health of the population.PM will still need to conduct postmarket surveillance and studies to determine whether the MRTP orders continues to be appropriate, including assessing the potential for increased use among youth.“Through the modified risk tobacco product application process, the FDA aims to ensure that information directed at consumers about reduced risk or reduced exposure from using a tobacco product is supported by scientific evidence and understandable,” said Mitch Zeller, director of the FDA’s Center for Tobacco Products.“Data submitted by the company shows that marketing these particular products with the authorized information could help addicted adult smokers transition away from combusted cigarettes and reduce their exposure to harmful chemicals, but only if they completely switch.”The IQOS Tobacco Heating System includes the electronic IQOS device that generates a nicotine-containing aerosol by heating tobacco-filled sticks wrapped in paper, specifically Marlboro Heatsticks, Marlboro Smooth Menthol Heatsticks and Marlboro Fresh Menthol Heatsticks.The FDA previously authorized the marketing of these products without modified risk information in April 2019.Shares in PM are currently trading down 14% year-to-date, and analysts have a cautiously optimistic Moderate Buy consensus on the stock’s outlook. This is with a $79 average analyst price target (8% upside potential). (See Philip Morris stock analysis on TipRanks).“We view today’s ruling as an important step forward on the risk continuum that could give IQOS some advantage in aiding consumers to fully switch to IQOS from cigarettes or vapor products. Remember that today’s order will also benefit Altria (MO), which will be selling IQOS in the US. The FDA did stress however that these products are not considered safe or FDA approved” noted Bank of America following the announcement.Related News: Facebook Quietly Testing Instagram Reels In India- Report AMC Pops 12% In After-Market Amid Report Of New Restructuring Deal Avalon Cancels 27 Of Boeing 737 Max Aircraft Order More recent articles from Smarter Analyst: * Avolon Cancels 27 Of Boeing 737 Max Aircraft Order * TechnipFMC Spikes 11% After-Hours On $1B+ Egypt Contract * AMC Pops 12% In After-Market Amid Report Of New Restructuring Deal To Avert Bankruptcy * Synaptics Snaps Up AVGO Wireless IoT Rights; Analyst Upgrades Stock
UST, John Middleton, Burger Söhne Holding AG, Juul, and Cronos Group are major companies owned by Altria.